SCHEMBL23770575

SCHEMBL23770575

Cc1ccccc1-c1nc(NSc2cccc(N)n2)ccc1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.37
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35
DPP4 P27487 2/20 0.35
NUDT1 P36639 3/20 0.34
NOS3 P29474 2/20 0.33
NOS2 P35228 2/20 0.33
HSP90AA1 P07900 1/20 0.33
EPHA4 P54764 1/20 0.33
CYP1A2 P05177 3/20 0.32
CYP2C19 P33261 3/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
LMNA P02545 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
DCUN1D1 Q96GG9 1/20 0.32
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770633 0.90 PLA2G7 (0.36) BACE1DPP4NUDT1HSP90AA1EPHA4
SCHEMBL23770676 0.89 ADORA2A (0.35) ADORA2ACTSDBACE1DPP4NUDT1
SCHEMBL23770590 0.89 ADORA2A (0.35) ADORA2ACTSDBACE1DPP4NOS3
SCHEMBL23770595 0.89 ADORA2A (0.35) ADORA2ACTSDBACE1DPP4NOS3
SCHEMBL23770584 0.86 GABRA1 (0.34) ADORA2ACTSDBACE1DPP4EPHA4
SCHEMBL23770551 0.86 PTPN1 (0.36) ADORA2ACTSDBACE1DPP4EPHA4
SCHEMBL23770411 0.81 NOS3 (0.33) NOS3NOS2ALDH1A1MAPK1
SCHEMBL23770571 0.81 NOS3 (0.33) NOS3NOS2
SCHEMBL23770602 0.81 NOS3 (0.33) NOS3NOS2
SCHEMBL23770550 0.79 NOS3 (0.31) NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed